Asthma Allergy Denmark: Hay-fever and allergy high-school 2019
EFA Member Astma Allergi Denmark organises a Hay-fever and Allergy High School. During the event, attendees can ask questions and get advice from Astma-Allergy...
New COPD development prediction: the ALEC Project
Although COPD has long been viewed as a predominantly smoking-related disease, there is increasing awareness that lifestyle and the environment contribute...
EFA continues to be the only patient organisation working with European Chemicals Agency
The European Chemicals Agency (ECHA) organised its annual Accredited Stakeholder Workshop on 21 March 2019 in Brussels to mainly discuss ECHA’s Strategic...
New IMI Project: 3TR
Despite the wide availability of treatments for autoimmune, inflammatory and allergic diseases, the response to therapy and the disease progression is...
Falsified medicines: New rules to enhance patients' safety
Falsified medicines are fake medicines that are dispensed as real, authorised, medicines. In reality, falsified medicines may contain inactive molecules,...
First guidance on new rules for certain medical devices by European Medical Agency
The European Medicines Agency (EMA) has published a first set of guidelines to help prepare for obligations coming from the new EU legislation on medical...
Patient Access Partnership launches the Future of Healthcare in the EU at the EP
EFA’s Susanna Palkonen, in her role as the chairperson of the Patient Access Partnership, launched a widely supported Statement on the Furure of Health...
European Parliament supports the adoption of an Indoor Air Quality Performance Certificate
On March 13th, the European Parliament plenary adopted the motion for a resolution ‘Clean Air for All: A Europe that Protects’, an initiative put forward...
EFA patient leaders make our Annual General Meeting 2019 in Brussels a success
On March 19th and 20th EFA celebrated the Annual General Meeting (AGM) of Members in Brussels, Belgium and launched the EFA annual report 2018, Shedding...
Allergy and respiratory patients present a European campaign calling for action for better care and prevention
On March 20th, the European Parliament Interest Group on Allergy and Asthma organised the last policy meeting of the current mandate, aimed at renewing...
Our takeaways from the ERS Satellite on COPD
FA took part in the last Satellite Precision Medicine training, organised by the European Respiratory Society (ERS) to deliver free cutting-edge education...
European Food Safety Authority discusses civil society concerns
The use and presence of pesticides, and their classification as endocrine disruptors where among the top food-related health concerns that civil society...
EFA calls for a European Air Quality strategy at the European Health Parliament
EFA was invited to bring the perspective of allergy and airways diseases patients to a debate on environment and human health at the 3rd Plenary of the...
EU digital prescriptions system kicks off in Finland and Estonia
We welcome the initiative giving patients the possibility to use digital prescriptions: prescriptions issued by a doctor at home can be issued when going...
Exposure to 25 carcinogens and mutagens will be reduced in the workplace
The third round of amendments on the Directive on Carcinogens and Mutagens at Work came to a close late January. The legislation seeks to impose obligatory...
European Medicines Agency reloactes to Amsterdam in March
The European Medicines Agency relocates to Amsterdam. The process will be completed by mid-March 2019. According to an EMA press release, the Dutch authorities...
Environmental agency calls for action to protect Europeans from air pollution and noise
Better alignment of social and environment policies and improved local action is necessary to tackle environmental justice issues. These are the results...
COP24 reports how much climate change and fossil fuels harm our respiratory health
The World Health Organisation (WHO) COP24 special report on health and climate change shows that climate change undermines people’s access to clean air,...
New EFA publication: the impact of Atopic Eczema on daily life
Atopic eczema is one of the most common non-communicable inflammatory diseases. Still, its impact on patients’ lives is often underestimated and ignored....
Quaterly Summary from EFA Working Groups
In December 2018 and January 2019 we organised follow-up calls with EFA Working Groups to discuss hot topics and share national experiences important for...